» Articles » PMID: 30811421

A Serum-free Medium Formulation Efficiently Supports Isolation and Propagation of Canine Adipose-derived Mesenchymal Stem/stromal Cells

Overview
Journal PLoS One
Date 2019 Feb 28
PMID 30811421
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Medium containing Fetal Bovine Serum (FBS) provides a supportive environment for isolation and expansion of mesenchymal stromal/stem cells (MSCs); however, the inherent variability of FBS may contribute to inconsistencies in cell growth and yield between batches of stem cell products. For this reason, we set out to develop a serum-free medium capable of supporting the in vitro expansion of MSCs. First a naïve serum-free medium was formulated by Sato's approach. Once it was established that the naïve serum-free medium supported the expansion of canine adipose-derived MSCs (Ad-MSCs), the serum-free medium was optimized by addition of growth factors. Combinations of growth factors were chosen and compared by their effect on cell proliferation and colony formation. Growth characteristics of canine adipose-derived MSCs cultured in the serum-free medium were comparable to those cultured in standard FBS containing medium. In addition, cell surface marker expression and differentiation potential of serum-free and FBS-based cultures were also comparable. However, a commercial serum-free medium developed for human MSC culture did not support growth of canine Ad-MSCs. In summary, canine Ad-MSCs isolated and cultured in serum-free medium retained the basic characteristics of MSCs cultured in FBS containing medium.

Citing Articles

Evaluation of enzymatic protocols to optimize efficiency of bovine adipose tissue-derived mesenchymal stromal cell isolation.

Heyman E, Devriendt B, De Vlieghere E, Goethals K, Van Poucke M, Peelman L NPJ Sci Food. 2024; 8(1):70.

PMID: 39353952 PMC: 11445272. DOI: 10.1038/s41538-024-00313-7.


Role of Adipose-Derived Mesenchymal Stem Cells in Bone Regeneration.

Lau C, Park S, Ethiraj L, Singh P, Raj G, Quek J Int J Mol Sci. 2024; 25(12).

PMID: 38928517 PMC: 11204188. DOI: 10.3390/ijms25126805.


Effect of Expansion Media on Functional Characteristics of Bone Marrow-Derived Mesenchymal Stromal Cells.

Jakl V, Popp T, Haupt J, Port M, Roesler R, Wiese S Cells. 2023; 12(16).

PMID: 37626914 PMC: 10453497. DOI: 10.3390/cells12162105.


A new animal product free defined medium for 2D and 3D culturing of normal and cancer cells to study cell proliferation and migration as well as dose response to chemical treatment.

Rafnsdottir O, Kiuru A, Teback M, Friberg N, Revstedt P, Zhu J Toxicol Rep. 2023; 10:509-520.

PMID: 37396848 PMC: 10313884. DOI: 10.1016/j.toxrep.2023.04.001.


Expansion and characterization of human limbus-derived stromal/mesenchymal stem cells in xeno-free medium for therapeutic applications.

Sahoo A, Damala M, Jaffet J, Prasad D, Basu S, Singh V Stem Cell Res Ther. 2023; 14(1):89.

PMID: 37061739 PMC: 10105964. DOI: 10.1186/s13287-023-03299-3.


References
1.
Screven R, Kenyon E, Myers M, Yancy H, Skasko M, Boxer L . Immunophenotype and gene expression profile of mesenchymal stem cells derived from canine adipose tissue and bone marrow. Vet Immunol Immunopathol. 2014; 161(1-2):21-31. DOI: 10.1016/j.vetimm.2014.06.002. View

2.
Bianco P . "Mesenchymal" stem cells. Annu Rev Cell Dev Biol. 2014; 30:677-704. DOI: 10.1146/annurev-cellbio-100913-013132. View

3.
Bianco P, Cao X, Frenette P, Mao J, Robey P, Simmons P . The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med. 2013; 19(1):35-42. PMC: 3998103. DOI: 10.1038/nm.3028. View

4.
Mather J . Making informed choices: medium, serum, and serum-free medium. How to choose the appropriate medium and culture system for the model you wish to create. Methods Cell Biol. 1998; 57:19-30. DOI: 10.1016/s0091-679x(08)61569-1. View

5.
Shipunova N, Petinati N, Drize N . Effect of hydrocortisone on multipotent human mesenchymal stromal cells. Bull Exp Biol Med. 2013; 155(1):159-63. DOI: 10.1007/s10517-013-2102-8. View